NAVB
$2.68
*
0.07
negative
2.55%

*Data as of May 25, 2012   | Navidea Biopharmaceuticals, Inc. | Industry: Health Care | HQ: Ohio, United States
 
 

Symbol List ViewsSymbol List Views

Stock DetailsStock Details

Stock DetailsCHARTS

Stock DetailsCOMPANY NEWS

Stock DetailsSTOCK ANALYSIS

Stock DetailsFUNDAMENTALS

Stock DetailsHOLDINGS

 Save stocks for next time
 |  Sponsored

NAVB News Headlines

Share |


   


Navidea Biopharmaceuticals Q1 12 Earnings Conference Call At 8:30 AM ET
5/3/2012 7:33:00 AM - RTT News

Company News for April 4, 2012 - Corporate Summary
4/4/2012 10:06:01 AM - Zacks.com

Navidea Biopharma To Present At Needham Conference; Webcast At 10:00 AM ET
4/3/2012 9:01:00 AM - RTT News

3M For A Buy And Hold Stock
10/10/2011 1:29:00 PM - Seeking Alpha

16 Stocks Under $5 Being Bought Up By Insiders And The Smart Money
9/16/2011 5:12:00 PM - Seeking Alpha

Thursday Options Recap
9/8/2011 4:06:00 PM - Seeking Alpha

5 Healthcare Insider Picks With A Recent History Of Winning
9/1/2011 7:10:00 PM - Seeking Alpha

Smart Buyers Slowly Returning To FDA Decision Plays
8/24/2011 1:15:00 PM - Seeking Alpha

2 Beaten Down Biotech Stocks With the Potential to Quadruple Your Money
8/18/2011 9:52:00 AM - Seeking Alpha

Buy and Sell Ideas Among Top Gainers During Tuesday's Market Rebound
8/10/2011 12:44:00 PM - Seeking Alpha

Healthcare Sector: Top Buy and Sell Ideas Based on Big Movers From Last Week
8/8/2011 8:45:00 PM - Seeking Alpha

Neoprobe: Why I'm Closing My Short Position
8/5/2011 11:11:00 AM - Seeking Alpha

A Look at 5 Stocks That Posted Big Gains Monday
7/26/2011 1:21:00 PM - Seeking Alpha

Top Buy and Sell Ideas Based on Monday's Biggest Gainers - Part 2
7/26/2011 9:42:00 AM - Seeking Alpha

Neoprobe: Did the Pivotal Studies Meet Their Primary Endpoints?
6/23/2011 11:21:00 PM - Seeking Alpha

Neoprobe: A Persuasive Biotech Speculative Investment
6/17/2011 11:06:00 AM - Seeking Alpha

Neoprobe: Follow-Up on ASCO, Citizen Petition and Readers' Comments
6/9/2011 4:08:00 AM - Seeking Alpha

The Short Case for Neoprobe: Skeptical of Its Primary Asset's Success
6/1/2011 9:15:00 AM - Seeking Alpha

Upcoming Biotech Trials and Potential Tribulations
4/13/2011 9:34:00 AM - Seeking Alpha

ImmunoCellular Therapeutics Meets AMEX Listing Requirements, Poised for Boost
2/28/2011 10:58:00 AM - Seeking Alpha